Merck & Co., Inc. logo
Merck & Co., Inc. (MRK)
Compare

Merck & Co., Inc. (MRK) EV/EBITDA Ratio: 14.96x

popular:market cap|pe ratio|revenue|price history|total return

Is Merck & Co., Inc.’s EV/EBITDA ratio high or low?

Merck & Co., Inc.'s EV/EBITDA ratio of 14.96x is 16% below its 5-year average of 17.79x, near the low end of its 5-year range (7.94x–53.05x).

The EV/EBITDA ratio for Merck & Co., Inc. (MRK) is 14.96x as of Tuesday, June 9, 2026. It is above its 12-month average by 50.16% (9.96x).

EV/Sales|P/E Ratio|EBITDA|All Metrics

MRK EV/EBITDA Ratio Chart

MRK EV/EBITDA Ratio
14.96x+74.97% 1Y
Zoom

MRK Average EV/EBITDA Ratio Chart

MRK Current vs Average EV/EBITDA Ratio Chart

MRK EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

14.96x

EV/EBITDA RATIO AVG TTM

9.96x

EV/EBITDA RATIO AVG 3Y

19.29x

EV/EBITDA RATIO AVG 5Y

17.79x

EV/EBITDA RATIO AVG 10Y

16.50x

EV/EBITDA RATIO AVG 15Y

14.19x

EV/EBITDA RATIO AVG 20Y

13.07x

CURRENT VS TTM AVG

+50.16%

CURRENT VS 3Y AVG

-22.46%

CURRENT VS 5Y AVG

-15.92%

CURRENT VS 10Y AVG

-9.33%

CURRENT VS 15Y AVG

+5.45%

CURRENT VS 20Y AVG

+14.48%

MRK Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
Merck & Co., Inc. (MRK)—14.96x9.96x19.29x17.79x
UnitedHealth Group Incorporated (UNH)$375.06B18.52x11.76x14.99x15.98x
AbbVie Inc. (ABBV)$398.27B27.38x30.39x23.51x19.97x
Amgen Inc. (AMGN)$185.96B13.42x13.25x14.19x13.96x
Thermo Fisher Scientific Inc. (TMO)$183.61B20.09x19.72x20.47x20.31x
Abbott Laboratories (ABT)$158.94B17.28x18.74x19.30x18.58x
Gilead Sciences, Inc. (GILD)$155.82B12.90x14.18x17.98x15.98x
Intuitive Surgical, Inc. (ISRG)$151.09B40.29x52.59x59.83x55.92x
Pfizer Inc. (PFE)$146.48B12.40x10.49x15.94x13.75x
Danaher Corporation (DHR)$133.37B21.94x23.47x23.87x22.36x

EV/EBITDA vs. its own history

At 15.0, EV/EBITDA is richer than usual — richer than 73% of its 20-year range.

20-year low

4.0

median

12.7

20-year high

53.0

cheaperricher

Understanding EV/EBITDA

Enterprise Value (EV) = Market Cap + Total Debt - Cash

EBITDA = Earnings Before Interest, Taxes, Depreciation & Amortization

EV/EBITDA is commonly used for comparing companies because:

  • It accounts for debt levels (capital structure neutral)
  • It removes effects of different depreciation policies
  • It can be compared across countries with different tax rates
  • It can remain available when net income is negative, if EBITDA is positive

Merck & Co., Inc. EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Merck & Co., Inc. EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The EV/EBITDA ratio for MRK stock is 14.96x.
Is Merck & Co., Inc.'s EV/EBITDA ratio high or low?
Merck & Co., Inc.'s EV/EBITDA ratio of 14.96x is 16% below its 5-year average of 17.79x, near the low end of its 5-year range (7.94x–53.05x).
What is the TTM average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The TTM average EV/EBITDA ratio for MRK stock is 9.96x.
What is the 3Y average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The 3Y average EV/EBITDA ratio for MRK stock is 19.29x.
What is the 5Y average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The 5Y average EV/EBITDA ratio for MRK stock is 17.79x.
What is the 10Y average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The 10Y average EV/EBITDA ratio for MRK stock is 16.50x.
What is the 15Y average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The 15Y average EV/EBITDA ratio for MRK stock is 14.19x.
What is the 20Y average EV/EBITDA ratio for Merck & Co., Inc. (MRK)?
The 20Y average EV/EBITDA ratio for MRK stock is 13.07x.

Merck & Co., Inc. EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-0914.96x
2026-06-0814.95x
2026-06-0515.09x
2026-06-0415.03x
2026-06-0314.42x
2026-06-0214.53x
2026-06-0114.48x
2026-05-2914.86x
2026-05-2814.99x
2026-05-2715.03x
2026-05-2614.97x
2026-05-2215.26x
2026-05-2114.55x
2026-05-2014.24x
2026-05-1914.37x
2026-05-1814.19x
2026-05-1514.06x
2026-05-1414.28x
2026-05-1314.29x
2026-05-1214.17x
2026-05-1114.05x
2026-05-0814.06x
2026-05-0714.16x
2026-05-0614.30x
2026-05-0514.26x
2026-05-0414.25x
2026-05-019.73x
2026-04-309.50x
2026-04-299.63x
2026-04-289.56x
2026-04-279.58x
2026-04-249.71x
2026-04-239.92x
2026-04-229.78x
2026-04-219.76x
2026-04-2010.11x
2026-04-1710.26x
2026-04-169.98x
2026-04-1510.17x
2026-04-1410.33x
2026-04-1310.34x
2026-04-1010.44x
2026-04-0910.54x
2026-04-0810.57x
2026-04-0710.27x
2026-04-0610.40x
2026-04-0210.40x
2026-04-0110.39x
2026-03-3110.35x
2026-03-3010.18x
2026-03-2710.30x
2026-03-2610.25x
2026-03-2510.28x
2026-03-2410.05x
2026-03-2310.00x
2026-03-209.88x
2026-03-199.88x
2026-03-189.91x
2026-03-1710.01x
2026-03-169.98x
2026-03-139.99x
2026-03-1210.02x
2026-03-1110.04x
2026-03-1010.11x
2026-03-0910.11x
2026-03-0610.01x
2026-03-0510.03x
2026-03-0410.35x
2026-03-0310.32x
2026-03-0210.44x
2026-02-2710.62x
2026-02-2610.28x
2026-02-2510.52x
2026-02-2410.63x
2026-02-2311.29x
2026-02-2011.16x
2026-02-1911.12x
2026-02-1811.11x
2026-02-1711.10x
2026-02-1311.08x
2026-02-1210.90x
2026-02-1110.90x
2026-02-1010.72x
2026-02-0910.77x
2026-02-0611.13x
2026-02-0510.94x
2026-02-0410.82x
2026-02-0310.61x
2026-02-0210.40x
2026-01-3010.14x
2026-01-299.98x
2026-01-289.85x
2026-01-279.94x
2026-01-269.90x
2026-01-239.96x
2026-01-2210.05x
2026-01-2110.21x
2026-01-2010.07x
2026-01-1610.02x
2026-01-1510.20x
2026-01-1410.20x
2026-01-139.97x
2026-01-1210.05x
2026-01-0910.16x
2026-01-0810.20x
2026-01-0710.00x
2026-01-0610.02x
2026-01-059.90x
2026-01-029.82x
2025-12-319.71x
2025-12-309.78x
2025-12-299.83x
2025-12-269.84x
2025-12-249.82x
2025-12-239.70x
2025-12-229.67x
2025-12-199.36x
2025-12-189.33x
2025-12-179.20x
2025-12-169.12x
2025-12-159.29x
2025-12-129.29x
2025-12-119.18x
2025-12-109.07x
2025-12-099.01x
2025-12-089.18x
2025-12-059.25x
2025-12-049.34x
2025-12-039.46x
2025-12-029.36x
2025-12-019.42x
2025-11-289.68x
2025-11-269.66x
2025-11-259.75x
2025-11-249.30x
2025-11-219.08x
2025-11-208.84x
2025-11-198.85x
2025-11-188.97x
2025-11-178.66x
2025-11-148.67x
2025-11-138.67x
2025-11-128.54x
2025-11-118.50x
2025-11-108.15x
2025-11-078.11x
2025-11-068.06x
2025-11-057.94x
2025-11-048.98x
2025-11-038.85x
2025-10-319.18x
2025-10-309.21x
2025-10-299.24x
2025-10-289.28x
2025-10-279.37x
2025-10-249.32x
2025-10-239.29x
2025-10-229.33x
2025-10-219.33x
2025-10-209.21x
2025-10-179.07x
2025-10-168.98x
2025-10-159.00x
2025-10-149.06x
2025-10-139.15x
2025-10-109.18x
2025-10-099.32x
2025-10-089.22x
2025-10-079.33x
2025-10-069.45x
2025-10-039.48x
2025-10-029.51x
2025-10-019.57x
2025-09-308.98x
2025-09-298.48x
2025-09-268.48x
2025-09-258.38x
2025-09-248.58x
2025-09-238.61x
2025-09-228.65x
2025-09-198.76x
2025-09-188.76x
2025-09-178.72x
2025-09-168.72x
2025-09-158.71x
2025-09-128.88x
2025-09-119.10x
2025-09-108.99x
2025-09-099.05x
2025-09-089.00x
2025-09-059.06x
2025-09-049.00x
2025-09-039.01x
2025-09-029.13x
2025-08-299.00x
2025-08-288.92x
2025-08-279.00x
2025-08-269.08x
2025-08-259.12x
2025-08-229.31x
2025-08-219.19x
2025-08-209.05x
2025-08-199.08x
2025-08-189.01x
2025-08-159.01x
2025-08-148.87x
2025-08-138.87x
2025-08-128.64x
2025-08-118.61x
2025-08-088.68x
2025-08-078.65x
2025-08-068.56x
2025-08-058.69x
2025-08-048.60x
2025-08-018.54x
2025-07-318.43x
2025-07-308.78x
2025-07-298.86x
2025-07-289.00x
2025-07-259.06x
2025-07-249.00x
2025-07-238.99x
2025-07-228.76x
2025-07-218.55x
2025-07-188.61x
2025-07-178.76x
2025-07-168.84x
2025-07-158.76x
2025-07-148.96x
2025-07-118.93x
2025-07-108.99x
2025-07-098.96x
2025-07-088.74x
2025-07-078.70x
2025-07-038.70x
2025-07-028.84x
2025-07-018.78x
2025-06-308.53x
2025-06-278.53x
2025-06-268.50x
2025-06-258.58x
2025-06-248.64x
2025-06-238.63x
2025-06-208.52x
2025-06-188.54x
2025-06-178.45x
2025-06-168.70x
2025-06-138.77x
2025-06-128.78x
2025-06-118.64x
2025-06-108.74x
2025-06-098.55x
2025-06-068.51x
2025-06-058.38x
2025-06-048.45x
2025-06-038.34x
2025-06-028.25x
2025-05-308.31x
2025-05-298.27x
2025-05-288.25x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

EV/SalesP/E RatioEBITDAAll Metrics

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.

Rahway, NJ
73,000 employees
www.merck.com
Healthcare / Drug Manufacturers - General
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Robert Davis
View full financials